Skip to content

Fai una donazione

Sostieni la ricerca per il diabete!

Gli studi AMD

AMD ANNALI

  • Pacilli A, Viazzi F, Fioretto P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Pontremoli, De Cosmo S, the AMD-Annals Study Group. Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: the AMD Annals Iniative. Diabetes Metab Res Rev 2016 – doi: 10.1002/dmrr.2873
  • Russo GT, De Cosmo S, Viazzi F, Pacilli A, Ceriello A, Genovese S, Guida P, Giorda C, Cucinotta D, Pontremoli R, Fioretto P, and the AMD-Annals Study Group. Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD Annals initiative. Diabetes Care 2016;39(12):2278-2287
  • Manicardi V, Russo G, Napoli A, Torlone E, Li Volsi P, Giorda CB, Musacchio N, Nicolucci A, Suraci C, Lucisano G, Rossi MC; on behalf of AMD Annals Study Group. Gender-disparities in adults with type 1 diabetes: more than a quality of care issue. A cross-sectional observational study from the AMD Annals initiative.
    PLoS ONE 11(10): e0162960
  • Forlani G, Giorda C, Manti R, Mazzella N, De Cosmo S, Rossi MC, Nicolucci A, Di Bartolo P, Ceriello A, Guida P, and AMD-Annals Study Group. The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes.
    Journal of Diabetes Research, vol. 2016, Article ID 2931985, 9 pages, 2016. doi:10.1155/2016/2931985
  • De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Pontremoli R and the AMD Annals study group. Predictors of chronic kidney disease in type 2 diabetes: a longitudinal study from the AMD Annals initiative.
    Medicine 2016;95:27:pe4007
  • De Cosmo S, Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Fioretto P, Pontremoli R and the AMD-Annals Study Group. Blood pressure status and the incidence of DKD in patients with hypertension and type 2 diabetes. Journal of Hypertension 2016, 34. Published Ahead-of-Print

Per la lista completa delle pubblicazioni Annali, si rimanda alla specifica sezione dello spazio online Annali AMD.

AMD REMINDERS

Studio BENCH-D

  • Nicolucci A, Rossi MC, Pellegrini F, Lucisano G, Pintaudi B, Gentile S, Marra G, Skovlund SE, Vespasiani G; BENCH-D Study Group. Benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study: protocol, tools, and population.
    Springerplus. 2014 Feb 12;3:83
  • Rossi MC, Lucisano G, Funnell M, Pintaudi B, Bulotta A, Gentile S, Scardapane M, Skovlund SE, Vespasiani G, Nicolucci A; BENCH-D Study Group. Interplay among patient empowerment and clinical and person-centered outcomes in type 2 diabetes. The BENCH-D study.
    Patient Educ Couns. 2015 Sep;98(9):1142-9
  • Pintaudi B, Lucisano G, Gentile S, Bulotta A, Skovlund SE, Vespasiani G, Rossi MC, Nicolucci A; BENCH-D Study Group. Correlates of diabetes-related distress in type 2 diabetes: Findings from the benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study

Studio BETADECLINE

  • Russo TG, Giorda CB, Cercone S, Nicolucci A, Cucinotta D; BetaDecline Study Group. Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study.
    PLoS One. 2014 Oct 27;9(10):e109702
  • Giorda CB, Russo GT, Cercone S, De Cosmo S, Nicolucci A, Cucinotta D. Incidence and correlated factors of beta cell failure in a 4-year-follow-up of patients with type 2 diabetes A longitudinal analysis of the BETADECLINE Study.
    Acta Diabetologica, First online: 18 May 2016

Studio DEMAND

  • Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda CB, Valentini U, Vespasiani G, De Cosmo S. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study.
    Nephrol Dial Transplant. 2008 Apr;23(4):1278-84
  • Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda C, Pomili B, Valentini U, Vespasiani G, De Cosmo S. Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study.
    Nutr Metab Cardiovasc Dis. 2010 Feb;20(2):110-6

Studio DYDA

  • Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, Lucci D, Maggioni AP, Tarantini L, Velussi M, Verdecchia P, Comaschi M. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study.
    Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):415-23

Studio HYPOS-1

  • Giorda CB, Ozzello A, Gentile S, Corsi A, Iannarelli R, Baccetti F, Lucisano G, Nicolucci A, Rossi MC; on behalf the HYPOS-1 Study Group. Incidence and correlates of hypoglycemia in type 2 diabetes. The Hypos-1 study.
    J Diabetes and Metabolism 2014;5:344
  • Giorda CB, Ozzello A, Gentile S, Agliloro A, Chiambretti A, Baccetti F, Gentile FM, Lucisano G, Nicolucci A, Rossi MC; HYPOS-1 Study Group of AMD. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study.
    Acta Diabetol. 2015 Oct;52(5):845-53

Studio SUBITO!AUDIT

  • Giorda CB, Mulas MF, Manicardi V, Suraci C, Guida P, Marafetti L, Nada E, Gentile S. Factors involved in a rapid and effective normalisation of HbA1c in newly diagnosed type 2 diabetic patients.
    Acta Diabetol. 2013 Feb;50(1):81-7
  • Nicolucci A, Rossi MC, Pintaudi B, Lucisano G, Scardapane M, Gentile S, Bulotta A, Skovlund SE, Vespasiani G, a nome del Gruppo di studio BENCH-D. Il miglioramento continuo della qualità dell’assistenza diabetologia attraverso la valutazione di indicatori clinici e umanistici.
    IHPB 2014;IV(Speciale):1-7

Studio SUBITO-DE

  • Corona G, Giorda CB, Cucinotta D, Guida P, Nada E; SUBITO-DE study group. The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.
    J Endocrinol Invest. 2013 Nov;36(10):864-8
  • Corona G, Giorda CB, Cucinotta D, Guida P, Nada E; a nome del Gruppo di studio SUBITO-DE. Lo studio SUBITO-DE: descrizione del campione.
    Il Giornale di AMD. 2013 gen-mar;16(1):25-31
  • Corona G, Giorda CB, Cucinotta D, Guida P, Nada E; Gruppo di studio SUBITO-DE. Sexual dysfunction at the onset of type 2 diabetes:the interplay of depression, hormonal and cardiovascular factors.
    J Sex Med. 2014 Aug;11(8):2065-73Risultati preliminari 2012

Studio QUASAR

  • Rossi MC, Nicolucci A, Comaschi M, Coscelli C, Cucinotta D, Ceriello A, De Cosmo S, Giorda C, Valentini U, Di Blasi P, Merante D, Vespasiani G. Analisi della correlazione tra aspetti strutturali-organizzativi, misure di processo e risultati dell’assistenza diabetologica. Razionale e disegno dello studio QUASAR.
    MeDia. 2007 mar;7(1):42-48
  • Rossi MC, Nicolucci A, Comaschi M, Coscelli C, Cucinotta D, Ceriello A, De Cosmo S, Giorda C, Otranto I, Pellegrini F, Pomili B, Valentini U, Di Blasi P, Merante D, Vespasiani G. Quali ‘indicatori di qualità utilizzare per la definizione dei profili di cura del diabete? Lo studio QUASAR (Quality Assessment Score and Cardiovascular Outcomes in Italian Diabetes Patients).
    MeDia. 2008 giu;8(2):79-86
  • Rossi MC, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, Bader G, Pellefrini F, Pomili B, Valentini U, Vespasiani G, Nicolucci A. Il raggiungimento dei target terapeutici nella pratica clinica:i risultati dello studio QUASAR.
    MeDia. 2009 dic;9(4):201-7
  • Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, Bader G, Pellegrini F, Valentini U, Vespasiani G, Nicolucci A; AMD-QUASAR Study Group. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study.
    Diabetes Care. 2011 Feb;34(2):347-52
  • Rossi MC. Lo studio AMD-QUASAR: report dell’analisi finale dei dati.
    Il Giornale di AMD. 2012 ott-dic;15(4):259-64

Score

Studio START DIAB

  • Gentile S, Ceriello A, Strollo F, on behalf of the AMD START DIAB Study Group. A Multicenter Italian Survey on Diabetes Care Units Reveals a Somewhat Slow Attitude in Treatment Guideline Implementation: Are We Dealing With Therapeutic Inertia?
    Diabetes Res Open J. 2016;2(2):33.44

Gruppo AMD: Terapia personalizzata

  • Ceriello A, Armentano V, De Micheli A, Gallo M, Perriello G, Gentile S. Documento di consenso. La personalizzazione della terapia: innovazione nella gestione del paziente con diabete di tipo 2.
    Il Giornale di AMD. 2011 gen-mar;14(1):35-45
  • Ceriello A, Gallo M, Armentano V, Perriello G, Gentile S, De Micheli A; Associazione Medici Diabetologi. Personalizing treatment in type 2 diabetes: a self-monitoring of blood glucose inclusive innovative approach.
    Diabetes Technol Ther. 2012 Apr;14(4):373-8
  • Ceriello A, Gallo M, Gentile S, Giorda CB, De Micheli A; Associazione Medici Diabetologi. To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) ‘personalised’?
    Diabetologia. 2012 Oct;55(10):2853-5
  • De Micheli A. Algoritmo DMT2.
    MeDia. 2012 giu;12(2):45-9
  • De Micheli A (a nome del Gruppo Terapia Personalizzata di AMD). Terapia personalizzata: l’algoritmo AMD.